
Boehringer Ingelheim is beginning a new push in lung disease across Europe after being approved by regulators in nine countries …

A complaint made by a pharmacist stating that the artwork image for Boehringer Ingelheim’s COPD drug Striverdi is misleading has …
Boehringer Ingelheim is to spend more than €100 million at its Dortmund site in Germany in order to expand the …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations

